#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	17090	16S	1529	1529	99.87	16S.l6.c4.ctg.1	2072	819.9	0	.	n	.	0	C451T	SNP	451	451	C	711	711	T	964	T,C	444,446	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	17090	16S	1529	1529	99.87	16S.l6.c4.ctg.1	2072	819.9	0	.	n	.	0	C1450T	SNP	1450	1450	C	1710	1710	T	1020	T,C	445,469	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	17090	16S	1529	1529	99.87	16S.l6.c4.ctg.1	2072	819.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1444	1444	C	1027	C	939	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	17090	16S	1529	1529	99.87	16S.l6.c4.ctg.1	2072	819.9	0	HET	.	.	.	C207T	.	207	207	C	467	467	C	904	C,T	634,184	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29912	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3522	846.9	0	.	n	.	0	T695C	SNP	695	695	T	1044	1044	C	911	C,T	841,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29912	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3522	846.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2320	2320	C	968	C	872	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29912	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3522	846.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2394	2394	A	990	A	915	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29912	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3522	846.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	2946	2946	C	1006	C,A	929,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	16	24	blaTEM	861	665	100.0	blaTEM.l15.c4.ctg.1	665	3.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Betalactam resistance
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	2380	folP	855	855	100.0	folP.l15.c17.ctg.1	1508	157.3	1	SNP	p	R229S	1	.	.	685	687	AGC	970	972	AGC	262;265;264	A;G;C	241;244;241	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6474	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3539	182.5	1	SNP	p	S91F	1	.	.	271	273	TTC	676	678	TTC	219;215;212	T;T;C	199;196;196	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6474	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3539	182.5	1	SNP	p	G95N	0	.	.	283	285	GGC	688	690	GGC	219;213;213	G;G;C	197;195;192	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6474	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3539	182.5	1	SNP	p	D95G	1	.	.	283	285	GGC	688	690	GGC	219;213;213	G;G;C	197;195;192	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1968	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1157	168.5	1	SNP	p	G45D	0	.	.	133	135	GGC	415	417	GGC	247;248;249	G;G;C	217;220;221	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1032	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	1012	101.7	0	.	n	.	0	A197.	DEL	197	197	A	600	600	A	253	A	231	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5936	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3087	191.9	1	SNP	p	D86N	0	.	.	256	258	GAC	623	625	GAC	224;224;223	G;A;C	208;201;210	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5936	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3087	191.9	1	SNP	p	S87R	1	.	.	259	261	CGT	626	628	CGT	222;228;233	C;G,A;T	209;211,1;215	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5936	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3087	191.9	1	SNP	p	R87I	0	.	.	259	261	CGT	626	628	CGT	222;228;233	C;G,A;T	209;211,1;215	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5936	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3087	191.9	1	SNP	p	R87W	0	.	.	259	261	CGT	626	628	CGT	222;228;233	C;G,A;T	209;211,1;215	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5936	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3087	191.9	1	SNP	p	S88P	0	.	.	262	264	TCC	629	631	TCC	233;231;227	T,C;C;C	217,1;218;216	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	5100	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2569	197.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1498	1500	GGC	259;261;259	G;G,A;C	240;239,1;236	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4900	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2284	213.6	1	SNP	p	A311V	0	.	.	931	933	GCC	1157	1159	GCC	267;269;270	G;C,T;C	245;245,1;245	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4900	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2284	213.6	1	SNP	p	I312M	1	.	.	934	936	ATG	1160	1162	ATG	270;268;268	A;T;G	247;246;242	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4900	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2284	213.6	1	SNP	p	V316T	1	.	.	946	948	ACC	1172	1174	ACC	269;269;270	A;C;C	246;245;246	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4900	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2284	213.6	1	SNP	p	T316P	0	.	.	946	948	ACC	1172	1174	ACC	269;269;270	A;C;C	246;245;246	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4900	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2284	213.6	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1673	1675	ACC	276;273;275	A;C;C,T	244;248;246,1	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4900	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2284	213.6	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1727	1729	GCG	269;271;273	G;C;G	249;245;249	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4900	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2284	213.6	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1727	1729	GCG	269;271;273	G;C;G	249;245;249	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4900	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2284	213.6	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1850	1852	GGT	202;203;201	G;G;T	188;189;189	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4900	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2284	213.6	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1859	1861	AGC	199;200;199	A;G;C	185;187;185	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4900	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2284	213.6	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1877	1879	CCG	167;171;172	C,G;C,G;G	129,9;131,1;132	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6568	ponA	2397	2397	100.0	ponA.l15.c17.ctg.1	3025	216.3	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1622	1624	CCG	250;250;251	C;C;G	214;228;216	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2534	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1857	135.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	588	588	C	212	C	194	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3290	porB1b	1038	1038	99.61	porB1b.l15.c17.ctg.1	1335	242.7	0	.	p	.	0	I45V	NONSYN	133	135	ATT	286	288	GTT	251;253;254	G,A;T,G;T	233,1;234,1;237	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3290	porB1b	1038	1038	99.61	porB1b.l15.c17.ctg.1	1335	242.7	0	.	p	.	0	G46A	NONSYN	136	138	GGC	289	291	GCC	256;257;255	G,A;C,A;C,A	239,1;239,1;236,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3290	porB1b	1038	1038	99.61	porB1b.l15.c17.ctg.1	1335	242.7	0	.	p	.	0	G48E	NONSYN	142	144	GGA	295	297	GAA	260;266;264	G;A,C;A	240;244,1;244	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3290	porB1b	1038	1038	99.61	porB1b.l15.c17.ctg.1	1335	242.7	0	.	p	.	0	G256D	NONSYN	766	768	GGT	919	921	GAT	275;274;274	G,T;A;T	247,1;246;249	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3290	porB1b	1038	1038	99.61	porB1b.l15.c17.ctg.1	1335	242.7	1	SNP	p	G120K	1	.	.	358	360	AAG	511	513	AAG	250;251;253	A;A;G	238;239;242	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3290	porB1b	1038	1038	99.61	porB1b.l15.c17.ctg.1	1335	242.7	1	SNP	p	A121N	1	.	.	361	363	AAC	514	516	AAC	255;254;250	A,G;A;C	240,1;243;237	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3290	porB1b	1038	1038	99.61	porB1b.l15.c17.ctg.1	1335	242.7	1	SNP	p	N121D	0	.	.	361	363	AAC	514	516	AAC	255;254;250	A,G;A;C	240,1;243;237	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	12180	rpoB	4179	4179	99.98	rpoB.l6.c30.ctg.1	4813	252.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1272	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	885	141.4	1	SNP	p	V57M	1	.	.	169	171	ATG	487	489	ATG	250;250;250	A;T;G,C	233;235;231,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
